1-24364186-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_198174.3(GRHL3):c.1696G>A(p.Glu566Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0405 in 1,489,000 control chromosomes in the GnomAD database, including 1,419 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_198174.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0304 AC: 4625AN: 152146Hom.: 98 Cov.: 33
GnomAD3 exomes AF: 0.0322 AC: 3301AN: 102552Hom.: 69 AF XY: 0.0319 AC XY: 1771AN XY: 55480
GnomAD4 exome AF: 0.0417 AC: 55679AN: 1336736Hom.: 1321 Cov.: 30 AF XY: 0.0409 AC XY: 26767AN XY: 654368
GnomAD4 genome AF: 0.0303 AC: 4619AN: 152264Hom.: 98 Cov.: 33 AF XY: 0.0293 AC XY: 2185AN XY: 74452
ClinVar
Submissions by phenotype
not specified Benign:1
- -
GRHL3-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
- -
Van der Woude syndrome 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at